How Unlocking the Nucleus in TNBC Biomarkers Could Change the Game for Black Breast Cancer Patients

Triple-negative breast cancer (TNBC) presents unique challenges, especially for Black women, who are disproportionately affected by this aggressive form of breast cancer. In this webinar, we will dive into the science behind TNBC biomarkers in the cell’s nucleus and explore how these discoveries could revolutionize the future of treatment and survival outcomes.

Our guest, Diva Melvin, PhD, Assistant Professor, Pre Health Advisor in the Biology Department at Tougaloo College, will present this in a patient-friendly format, this discussion from a scientist’s perspective on the latest research developments in TNBC, focusing on how these advancements can benefit the Black community. You’ll learn about the significance of this research, its potential as a game-changer in targeted therapy, and what this means for Black breast cancer patients navigating TNBC. Join us for an informative conversation on ways to bridge the gap between cutting-edge research and real-world impact.